AC
Armistice Capital’s Enanta Pharmaceuticals ENTA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,000,000
| Closed | -$10.4M | – | 255 |
|
2024
Q3 | $10.4M | Sell |
1,000,000
-96,000
| -9% | -$995K | 0.17% | 89 |
|
2024
Q2 | $14.2M | Sell |
1,096,000
-140,000
| -11% | -$1.82M | 0.18% | 77 |
|
2024
Q1 | $21.6M | Sell |
1,236,000
-828,000
| -40% | -$14.5M | 0.29% | 61 |
|
2023
Q4 | $19.4M | Sell |
2,064,000
-36,000
| -2% | -$339K | 0.27% | 59 |
|
2023
Q3 | $23.5M | Buy |
2,100,000
+64,000
| +3% | +$715K | 0.36% | 47 |
|
2023
Q2 | $43.6M | Buy |
2,036,000
+24,000
| +1% | +$514K | 0.63% | 32 |
|
2023
Q1 | $81.4M | Sell |
2,012,000
-66,000
| -3% | -$2.67M | 1.17% | 15 |
|
2022
Q4 | $96.7M | Buy |
2,078,000
+6,000
| +0.3% | +$279K | 1.69% | 11 |
|
2022
Q3 | $107M | Buy |
2,072,000
+2,000
| +0.1% | +$104K | 1.86% | 8 |
|
2022
Q2 | $97.8K | Buy |
2,070,000
+946,000
| +84% | +$44.7K | 1.71% | 10 |
|
2022
Q1 | $80M | Buy |
1,124,000
+68,000
| +6% | +$4.84M | 1.55% | 10 |
|
2021
Q4 | $79M | Sell |
1,056,000
-780,000
| -42% | -$58.3M | 1.29% | 12 |
|
2021
Q3 | $104M | Sell |
1,836,000
-164,000
| -8% | -$9.32M | 1.77% | 7 |
|
2021
Q2 | $88M | Buy |
2,000,000
+352,000
| +21% | +$15.5M | 1.58% | 9 |
|
2021
Q1 | $81.3M | Buy |
1,648,000
+292,000
| +22% | +$14.4M | 1.87% | 8 |
|
2020
Q4 | $57.1M | Buy |
1,356,000
+832,000
| +159% | +$35M | 1.94% | 10 |
|
2020
Q3 | $24M | Buy |
524,000
+200,000
| +62% | +$9.16M | 0.87% | 41 |
|
2020
Q2 | $16.3M | Sell |
324,000
-244,000
| -43% | -$12.3M | 0.71% | 48 |
|
2020
Q1 | $29.2M | Buy |
568,000
+174,105
| +44% | +$8.95M | 1.81% | 17 |
|
2019
Q4 | $24.3M | Sell |
393,895
-186,105
| -32% | -$11.5M | 1.4% | 18 |
|
2019
Q3 | $34.8M | Buy |
580,000
+200,000
| +53% | +$12M | 2.31% | 9 |
|
2019
Q2 | $32.1M | Buy |
380,000
+8,000
| +2% | +$675K | 2.02% | 13 |
|
2019
Q1 | $35.5M | Sell |
372,000
-128,000
| -26% | -$12.2M | 1.94% | 11 |
|
2018
Q4 | $35.4M | Buy |
500,000
+44,000
| +10% | +$3.12M | 2.68% | 7 |
|
2018
Q3 | $39M | Buy |
456,000
+332,000
| +268% | +$28.4M | 2.34% | 7 |
|
2018
Q2 | $14.4M | Sell |
124,000
-8,000
| -6% | -$927K | 0.94% | 27 |
|
2018
Q1 | $10.7M | Buy |
132,000
+44,000
| +50% | +$3.56M | 0.82% | 36 |
|
2017
Q4 | $5.16M | Sell |
88,000
-20,000
| -19% | -$1.17M | 0.51% | 46 |
|
2017
Q3 | $5.05M | Sell |
108,000
-156,000
| -59% | -$7.3M | 0.6% | 41 |
|
2017
Q2 | $9.5M | Sell |
264,000
-8,000
| -3% | -$288K | 1.21% | 32 |
|
2017
Q1 | $8.38M | Buy |
272,000
+44,000
| +19% | +$1.36M | 1.73% | 22 |
|
2016
Q4 | $7.64M | Buy |
228,000
+16,000
| +8% | +$536K | 1.81% | 26 |
|
2016
Q3 | $5.64M | Sell |
212,000
-28,000
| -12% | -$745K | 1.81% | 20 |
|
2016
Q2 | $5.29M | Buy |
+240,000
| New | +$5.29M | 2.01% | 19 |
|